Published October 3, 2020 | Version v1
Journal article

Mitotic cells can repair DNA double-strand breaks via a homology-directed pathway

  • 1. Department of Biological Sciences, Ibaraki University, Mito, Ibaraki (Japan)
  • 2. Department of Molecular Cancer Biology, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka (Japan)
  • 3. Radiation Biology Center, Kyoto University, Kyoto (Japan)

Description

The choice of repair pathways of DNA double-strand breaks (DSBs) is dependent upon the cell cycle phases. While homologous recombination repair (HRR) is active between the S and G2 phases, its involvement in mitotic DSB repair has not been examined in detail. In the present study, we developed a new reporter assay system to detect homology-directed repair (HDR), a major pathway used for HRR, in combination with an inducible DSB-generation system. As expected, the maximal HDR activity was observed in the late S phase, along with minimal activity in the G1 phase and at the G1/S boundary. Surprisingly, significant HDR activity was observed in M phase, and the repair efficiency was similar to that observed in late S phase. HDR was also confirmed in metaphase cells collected with continuous colcemid exposure. ChIP assays revealed the recruitment of RAD51 to the vicinity of DSBs in M phase. In addition, the ChIP assay for gamma-H2AX and phosphorylated DNA-PKcs indicated that a part of M-phase cells with DSBs could proceed into the next G1 phase. These results provide evidence showing that a portion of mitotic cell DSBs are undoubtedly repaired through action of the HDR repair pathway.

Availability note (English)

Available from http://dx.doi.org/10.1093/jrr/rraa095; Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779344

Additional details

Publishing Information

Journal Title
Journal of Radiation Research
Journal Volume
62
Journal Issue
1
Journal Page Range
p. 25-33
ISSN
0449-3060

Optional Information

Copyright
Copyright (c) The Author(s) 2020. Published by Oxford University Press on behalf of The Japanese Radiation Research Society and Japanese Society for Radiation Oncology.
Notes
PMCID: PMC7779344; PMID: 33009557; PMID: 33009557; PUBLISHER-ID: rraa095; OAI: oai:pubmedcentral.nih.gov:7779344